Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Mégane Fernandez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectiologie et Santé Publique, Université de Tours, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, F-37380 N…. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Animals, Newborn, Toll-Like Receptor 6. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: the French Institut Carnot France Futur Elevage, Microbes Santé, Région Centre-Val de Loire.
Abstract (Originalsprache)
By providing innate immune modulatory stimuli, the early-life immune system can be enhanced to increase resistance to infections. Activation of innate cell surface receptors called pattern recognition receptors by Toll-like receptor (TLR) ligands is one promising approach that can help to control infections as described for listeriosis and cryptosporidiosis. In this study, the effect of TLR2/TLR1 and TLR2/TLR6 agonists was compared when injected into neonatal mice. Surprisingly, the stimulation of TLR2/TLR6 led to the death of the neonatal mice, which was not observed in adult mice. The TLR2/TLR6 agonist administration induced higher systemic and intestinal inflammation in both adult and neonatal mice when compared with TLR2/TLR1 agonist. The mortality of neonatal mice was interferon γ dependent and involved the intestinal production of interleukin-22 and interleukin-17A. This study clearly demonstrates that targeting TLRs as new control strategy of neonatal infections has to be used with caution. Depending on its heterodimeric form, TLR2 stimulation can induce more or less severe adverse effects relying on the age-related immune functions of the host.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectiologie et Santé Publique, Université de Tours, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, F-37380 Nouzilly, France.
- Centre National de la Recherche Scientifique UMR6047, Institut National de la Santé et de la Recherche Médicale U1306, Unité de Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur, Université Paris Cité, Par…
ORCID-Profile: Sonia Lacroix-Lamandé
Förderung
- the French Institut Carnot France Futur Elevage
- Microbes Santé
- Région Centre-Val de Loire
- Université Paris Cité
- BioSPC
Zitieren
APA
Fernandez, M., Pezier, T., Papadopoulos, S., Laurent, F., Werts, C., & Lacroix-Lamandé, S. (2024). Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae140
Vancouver
Fernandez M, Pezier T, Papadopoulos S, Laurent F, Werts C, Lacroix-Lamandé S. Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae140
BibTeX
@article{Fernandez2024,
author = {Fernandez, Mégane and Pezier, Tiffany and Papadopoulos, Stylianos and Laurent, Fabrice and Werts, Catherine and Lacroix-Lamandé, Sonia},
title = {Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae140}
}
EUVIMED